Myeloma
Gloucester Pharmaceuticals Announces Positive Interim Results of Phase I/II Study in Patients with Multiple Myeloma at the 2007 American Society of Hematology (ASH) Annual Meeting
Published in Gastroenterology Week, December 24th, 2007
Gloucester Pharmaceuticals, Inc., an oncology focused specialty pharmaceutical company, announced encouraging interim results from an investigator-sponsored phase I/II dose-escalation study investigating the use of the Company's lead product, romidepsin, in combination with bortezomib (Velcade(R)) and dexamethasone to treat patients with relapsed/refractory multiple myeloma. These interim results were reported at the 49th Annual Meeting of the American Society of Hematology (ASH) being held in Atlanta, Georgia. Full text of the abstract #1167 can be viewed on the ASH website at www.hematology.org.
In a poster session on Saturday, December 8th, Miles Prince, M.D., Chair...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gastroenterology Week
More Articles from Gastroenterology Week
- Anxiety Disorders
Is there a developmental component to the risk for depression? - Breast Cancer
Accuracy of diagnostic mammograms varies by radiologist - Cancer
Diagnostic mammogram readings vary extensively by radiologist - Diabetes
Living donors may be best source of insulin-producing islets for diabetes treatment - Food Poisoning
Fresh-cut produce washing practices can minimize food-borne illness risks - Allergic Reactions
31 Million Americans Suffer From Sinus Infections - More from this issue of Gastroenterology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
